Homozygosity for the W151X stop mutation in the Delta 7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: Retrospective molecular diagnosis
J. Loffler et al., Homozygosity for the W151X stop mutation in the Delta 7-sterol reductase gene (DHCR7) causing a lethal form of Smith-Lemli-Opitz syndrome: Retrospective molecular diagnosis, AM J MED G, 95(2), 2000, pp. 174-177
Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital anomalies syndro
me caused by an abnormality in cholesterol metabolism. The clinical severit
y may vary from very mild to lethality in utero, making diagnosis difficult
at both ends of the spectrum. Patients with severe SLOS might often escape
diagnosis because they die before the correct diagnosis is made. We descri
be an Austrian family whose first child died neonatally with multiple conge
nital anomalies. The second pregnancy was terminated because the fetus show
ed similar severe anomalies ultrasonographically. A further pregnancy ended
in a spontaneous first trimester abortion, Clinical diagnosis of SLOS was
not considered until the autopsy of the fetus of the terminated pregnancy.
Because no material for biochemical testing was available we performed muta
tional analysis of the DHCR7 gene from paraffin-embedded tissue and a Guthr
ie card focusing on mutations known to cause a severe SLOS phenotype, This
demonstrated homozygosity for the mutation W151X, which has been demonstrat
ed to be a functional null mutation. Our data confirm the concept that homo
zygosity for functional null alleles of the DHCR7 locus results in intraute
rine or perinatal lethality. Furthermore, our findings suggest the usefulne
ss of molecular studies of stored material in similarly affected cases wher
e no material for biochemical analysis is available. (C) 2000 Wiley-Liss, I
nc.